Evidence map›Paper›PMID 32738408›Full record

Trial reportContemporary clinical trials2020

Positive Health Check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care.

Megan A Lewis, Camilla Harshbarger, Carla Bann, Olivia Burrus, Susana Peinado, Bryan R Garner, Olga Khavjou, Ram K Shrestha, Shawn Karns, Craig B Borkowf and 9 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05783297 (Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05783297 nacompletednot on this mapstarted 2023, after this paper: background citation

Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

TypeinterventionalSponsorAmy K. Johnson, PhD, MSWRan2023 to 2025Enrolled210ConditionsHIV InfectionsArmsTreatment Text (TXTXT), Standard of Care
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Megan A LewisRTI International, Research Triangle Park, NC, United States of America. Electronic address: melewis@rti.org.
Camilla HarshbargerCenters for Disease Control and Prevention, Atlanta, GA, United States of America.
Carla BannRTI International, Research Triangle Park, NC, United States of America.
Olivia BurrusRTI International, Research Triangle Park, NC, United States of America.
Susana PeinadoRTI International, Research Triangle Park, NC, United States of America.
Bryan R GarnerRTI International, Research Triangle Park, NC, United States of America.
Olga KhavjouRTI International, Research Triangle Park, NC, United States of America.
Ram K ShresthaCenters for Disease Control and Prevention, Atlanta, GA, United States of America.
Shawn KarnsRTI International, Research Triangle Park, NC, United States of America.
Craig B BorkowfCenters for Disease Control and Prevention, Atlanta, GA, United States of America.
Brittany A ZulkiewiczRTI International, Research Triangle Park, NC, United States of America.
Alexa OrtizRTI International, Research Triangle Park, NC, United States of America.
Carla A GalindoCenters for Disease Control and Prevention, Atlanta, GA, United States of America.
Michelle DallaPiazzaRutgers New Jersey Medical School, Newark, NJ, United States of America.
Pam HolmNO AIDS Task Force dba CrescentCare, New Orleans, LA, United States of America.
Vincent C MarconiDivision of Infectious Diseases, Emory University School of Medicine, Emory Vaccine Center, and Rollins School of Public Health, Atlanta, GA, United States of America; Atlanta VA Medical Center, Decatur, GA, United States of America.
Charurut SomboonwitUniversity of South Florida, Morsani College of Medicine, Tampa, FL, United States of America.
Shobha SwaminathanRutgers New Jersey Medical School, Newark, NJ, United States of America.
Positive Health Check Study Team
RTI International · USCenters for Disease Control and Prevention · USRutgers, The State University of New Jersey · USEmory University · USNew Orleans AIDS Task Force · USUniversity of South Florida · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Positive Health Check Evaluation Trial Yr. 5U18PS004967 · PS · RESEARCH TRIANGLE INSTITUTE · PI LEWIS, MEGAN A · 2015 to 2019
$5.3M
ACL HHS U18PS004967NCHHSTP CDC HHS U18 PS004967NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

For people with HIV, important transmission prevention strategies include early initiation and adherence to antiretroviral therapy and retention in clinical care with the goal of reducing viral loads as quickly as possible. Consequently, at this point in the HIV epidemic, innovative and effective strategies are urgently needed to engage and retain people in health care to support medication adherence. To address this gap, the Positive Health Check Evaluation Trial uses a type 1 hybrid randomized trial design to test whether the use of a highly tailored video doctor intervention will reduce HIV viral load and retain people with HIV in health care. Eligible and consenting patients from four HIV primary care clinical sites are randomly assigned to receive either the Positive Health Check intervention in addition to the standard of care or the standard of care only. The primary aim is to determine the effectiveness of the intervention. A second aim is to understand the implementation potential of the intervention in clinic workflows, and a third aim is to assess the costs of intervention implementation. The trial findings will have important real-world applicability for understanding how digital interventions that take the form of video doctors can be used to decrease viral load and to support retention in care among diverse patients attending HIV primary care clinics.

Indexed as

Anti-HIV AgentsHIV InfectionsHumansMedication AdherencePrimary Health CareViral LoadAnti-HIV AgentsHIVMedication adherenceRetention in careType 1 hybrid trialVideo doctor interventionViral load

Identifiers

PMID32738408
PMCPMC8820779
OpenAlexW3046012284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.